Conference 2022

The Immunotherapy for Infectious Diseases Conference - IIDC 2022

NOVEL WAYS TO FIGHT PATHOGENS

AULA MAGNA, University of Pavia
Corso Str. Nuova, 65
27100 Pavia PV, ITALY

June 20-23rd, 2022

#IIDC2022

Session videos are now available

Watch the videos

Conference Information

The “Immunotherapy for Infectious Diseases Conference” brings together academia, small biotech, big pharma and regulatory bodies invested in the discovery of novel therapeutic strategies.

Infectious diseases remain a leading cause of morbidity and mortality worldwide necessitating novel and innovative therapeutics. The recent COVID-19 disease caused by a SARS-CoV-2 has taught us how to react in a pandemic situation connecting scientists, researchers, medical doctors, private and public companies in order to develop and produce safe and effective vaccines as well as therapeutic antibodies in fast times. Current and future challenges range from neglected diseases affecting the poorest countries to antimicrobial resistant pathogens in modern hospitals; from rare but deadly infections affecting few to the threat of potential global pandemics; from pathogens reaching new geographical areas due to climate changes to disease reemerging due to lack of vaccination coverage.

The ability of the human immune system to fight pathogens can be exploited for effective therapeutic strategies. Recombinant and further engineered antibodies can be used as active ingredients, as targeting agents to selectively deliver drugs or to establish novel vaccination strategies. Bringing a novel therapy to the patients requires the combined effort of several players, all of which are brought together in the “Immunotherapy for Infectious Diseases Conference”, with world high caliber speakers and participants.

The congress is organized in the USA and Europe in alternating years with the aim to serve as a forum to exchange ideas and foster cross-disciplinary collaborations.

We have assembled an exciting program for the conference that features keynote seminars from international experts in the field, talks from both academia and industry as well as presentations on novel therapeutic techniques for immunotherapy. The conference program also contains poster sessions.

The Immunotherapy for Infectious Diseases conference will be held on June 20-23rd, 2022 in Pavia C/O AULA MAGNA, University of Pavia.

Public

Young scientists & Academics

  • Includes all lunches (no dinners)!
  • Comfortable Seat
  • Coffee Break
  • Poster session
  • Certificate
  • Registration will NOT includes the cost of accommodation
Register
Private

Private

  • Includes all lunches (no dinners)!
  • Comfortable Seat
  • Coffee Break
  • Poster session
  • Certificate
  • Registration will NOT includes the cost of accommodation
Register

Event Schedule

Monday June 20, 2022
SESSION 1 – ANTIBODY-BASED DRUG DEVELOPMENT

Tuesday June 21, 2022
SESSION 2 – Part 1 - IMMUNOTHERAPY AGAINST EMERGING VIRAL INFECTIOUS DISEASES
SESSION 2 – Part 2 - IMMUNOTHERAPY AGAINST EMERGING VIRAL INFECTIOUS DISEASES

Wednesday June 22, 2022
SPECIAL SESSION 3 – IMMUNOTHERAPY AGAINST SARS-COV-2
SESSION 4 – IMMUNOTHERAPY AGAINST BACTERIAL AND NON VIRAL INFECTIOUS DISEASES

Thursday June 23, 2022
SESSION 5 – 3RS PRINCIPLES IN BIOTECHNOLOGICAL AND MEDICAL APPLICATIONS

12:00-2:15 PM Registration - MAGNA HALL, University of Pavia
WELCOME COCKTAILS - SALON OF THE RECTORATE, University of Pavia
2:15 PM WELCOME REMARKS
Welcome greetings from Prof. Fausto Baldanti, University of Pavia and Policninico San Matteo Foundation Welcome greetings from the organizers Livia Visai, Michael Hust, MireiaPelegrin, Luca Varani and Luigi Calzolai
2:30-5:40 PM SESSION 1
ANTIBODY-BASED DRUG DEVELOPMENT: MAGNA HALL, University of Pavia [Moderators: Luca Varani and Harold Marcotte]
2:30-3:10 PM

Infectious Diseases and Antibody Therapy

Keynote Speaker: Davide Corti, Humabs BioMed, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland
3:10-3:40 PM

Antibody-mediated immunomodulation: a better understanding for better antiviral immunotherapies

Mireia Pelegrin, Institute for Regenerative Medicine and Biotherapy, INSERM, Montpellier, France
3:40-4:10 PM

Recombinant snakebite antivenoms based on broadly-neutralizing oligoclonal antibodies

Andreas Hougaard Laustsen-Kiel, Technical University of Denmark, Denmark
4:10-4:30 PM

Break - SALON OF THE RECTORATE, University of Pavia

4:30-5:00 PM

Public-private partnerships for development of mAbs against neglected diseases

James Pettitt, Director, Nonclinical Services, Mapp Biopharmaceutical Inc., San Diego, CA, USA
5:00-5:30 PM

Quality Assessment of Biologics and Biosimilars at Atomic Resolution

Anna Codina, Bruker Biospin
5:30-5:50 PM

Selected abstracts for 1 oral presentation

5:50-6:10 PM

Selected abstracts for 1 oral presentation

FREE DINNER

Photo of the conference participants and speakers will be taken during the event .
Do not miss this opportunity!

PREVIOUS CONFERENCE:
November 12-14th, 2018, Galveston, Texas, USA

Immunotherapies and Innovations for Infectious Diseases Congress 2022Immunotherapies and Innovations for Infectious Diseases Congress 2022